amiodarone has been researched along with Acute Coronary Syndrome in 9 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with persistent or paroxysmal atrial fibrillation and at least 1 risk factor for cardiovascular hospitalization were randomized to receive dronedarone (400 mg BID) or double-blind matching placebo and followed up for a minimum of 1 year to a common termination at 30 months." | 7.75 | Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial ( Connolly, SJ; Crijns, HJ; Gaudin, C; Hohnloser, SH; Page, RL; Torp-Pedersen, C; van Eickels, M, 2009) |
| "Several key reports from the American Heart Association meeting, held in Orlando (FL, USA) in November 2011, are presented related to anti-thrombotic therapy in acute coronary syndrome and the use of dronedarone in permanent atrial fibrillation is discussed in this brief (and selective) overview of this meeting." | 3.78 | Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS-TIMI 51, TRACER and PALLAS. ( Lip, GY; Shantsila, A, 2012) |
| "Patients with persistent or paroxysmal atrial fibrillation and at least 1 risk factor for cardiovascular hospitalization were randomized to receive dronedarone (400 mg BID) or double-blind matching placebo and followed up for a minimum of 1 year to a common termination at 30 months." | 3.75 | Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial ( Connolly, SJ; Crijns, HJ; Gaudin, C; Hohnloser, SH; Page, RL; Torp-Pedersen, C; van Eickels, M, 2009) |
| "An intravenous bolus injection and subsequent continuous infusion of NIF at a relatively low dosage were effective in treating severe ventricular tachyarrhythmias complicating ACS, reducing the potential risk of proarrhythmia." | 2.74 | Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome. ( Abe, A; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Shimizu, H; Tsukada, T; Yoshino, H; Yusu, S, 2009) |
| "Neurogenic stunned myocardium is an unusual clinical entity." | 1.42 | [Neurogenic stunned myocardium in Pediatrics. A case report]. ( Alados Arboledas, FJ; Expósito-Montes, JF; Martínez Padilla, MC; Millán-Bueno, MP; Millán-Miralles, L; Santiago-Gutierrez, C, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alados Arboledas, FJ | 1 |
| Millán-Miralles, L | 1 |
| Millán-Bueno, MP | 1 |
| Expósito-Montes, JF | 1 |
| Santiago-Gutierrez, C | 1 |
| Martínez Padilla, MC | 1 |
| Horner, SM | 1 |
| Yusu, S | 1 |
| Ikeda, T | 1 |
| Mera, H | 1 |
| Miyakoshi, M | 1 |
| Miwa, Y | 1 |
| Abe, A | 1 |
| Tsukada, T | 1 |
| Ishiguro, H | 1 |
| Shimizu, H | 1 |
| Yoshino, H | 1 |
| Connolly, SJ | 1 |
| Crijns, HJ | 1 |
| Torp-Pedersen, C | 1 |
| van Eickels, M | 1 |
| Gaudin, C | 1 |
| Page, RL | 1 |
| Hohnloser, SH | 1 |
| Ohno, M | 1 |
| D'Ascenzi, F | 1 |
| Iadanza, A | 1 |
| Zacà, V | 1 |
| Pierli, C | 1 |
| Mondillo, S | 1 |
| Ayalloore, SG | 1 |
| LeLorier, P | 1 |
| Bukowska, A | 1 |
| Hammwöhner, M | 1 |
| Sixdorf, A | 1 |
| Schild, L | 1 |
| Wiswedel, I | 1 |
| Röhl, FW | 1 |
| Wolke, C | 1 |
| Lendeckel, U | 1 |
| Aderkast, C | 1 |
| Bochmann, S | 1 |
| Chilukoti, RK | 1 |
| Mostertz, J | 1 |
| Bramlage, P | 1 |
| Goette, A | 1 |
| Shantsila, A | 1 |
| Lip, GY | 1 |
1 review available for amiodarone and Acute Coronary Syndrome
| Article | Year |
|---|---|
[Recent progress of strategy of the therapy for the complication of ACS].
Topics: Acute Coronary Syndrome; Amiodarone; Defibrillators, Implantable; Humans; Vasodilator Agents | 2010 |
1 trial available for amiodarone and Acute Coronary Syndrome
| Article | Year |
|---|---|
Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiograp | 2009 |
7 other studies available for amiodarone and Acute Coronary Syndrome
| Article | Year |
|---|---|
[Neurogenic stunned myocardium in Pediatrics. A case report].
Topics: Acute Coronary Syndrome; Amiodarone; Cerebellar Neoplasms; Child, Preschool; Diagnosis, Differential | 2015 |
Dronedarone in atrial fibrillation.
Topics: Acute Coronary Syndrome; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Dr | 2009 |
Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrill | 2009 |
Subocclusion of the sinus node artery during coronary angioplasty: arrhythmological considerations.
Topics: Acute Coronary Syndrome; Amiodarone; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Atrial | 2010 |
Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Isc
Topics: Acetanilides; Acute Coronary Syndrome; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; E | 2011 |
Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs.
Topics: Acute Coronary Syndrome; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blotting, | 2012 |
Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS-TIMI 51, TRACER and PALLAS.
Topics: Acute Coronary Syndrome; American Heart Association; Amiodarone; Anti-Arrhythmia Agents; Anticoagula | 2012 |